ExoLab Italia funding news – L’Aquila-based ExoLab Italia Raises €5 Million in Series A Round Funding

Gabriele Campi, CEO of ExoLab Italia said, “The funds raised will allow us to implement an ambitious strategic plan, which includes industrial scale-up, internationalisation and a decisive investment in human and territorial capital,”.

ExoLab Italia was first supported by Scientifica Venture Capital, which helped the company grow from the beginning and continues to be an important partner.

The company is using plant-derived exosomes—tiny particles from fruit—to improve ingredients in cosmetics, pharmaceuticals, and nutraceuticals. With its own technology and strong research, ExoLab Italia plans to turn Italy’s organic agriculture into new, useful compounds for different industries.

Read also - Pixel Photonics funding news – Munster-based DeepTech Startup Pixel Photonics Secures €1 Million in Funding

With the new funding, ExoLab Italia will move from its current 300 m² facility to a larger 1,000 m² plant in L’Aquila, increasing its production capacity. The company also plans to hire 20 new employees over the next three years to help with its growth.

Alessandro Scortecci, Chief Direct Investment Officer of CDP Venture Capital Sgr said, "Investors see significant potential in ExoLab’s plant-derived exosome technology, particularly in biomedical and wellness applications. We are particularly proud of this partnership with ExoLab, Plant-derived exosomes are emerging as a revolutionary frontier in biomedical technologies and sciences and, thanks to the advanced research conducted by the ExoLab team, they stand out as a potential game changer in the cosmetic, nutraceutical and pharmaceutical sectors. Their extraordinary bioactive properties, combined with high biocompatibility, make them ideal for developing innovative applications aimed at improving health and well-being, opening new horizons for ever-evolving markets.”

ExoLab Italia plans to expand into international markets focusing on key areas in Europe and beyond. The company aims to form local partnerships and increase its global brand presence.

As it grows, ExoLab will continue its research to find more uses for plant-derived exosomes in health and wellness.

About ExoLab Italia

ExoLab Italia was co-founded in 2020 by Mariantonia Logozzi (CTO) and Stefano Fais (Scientific Director). They create innovative raw materials from plant exosomes, sourced from Italian organic farming, to revolutionize nutraceutical and dermocosmetic products.